Exenatide corrects postprandial hyperglycaemia in young people with cystic fibrosis and impaired glucose tolerance: A randomized crossover trial

Diabetes, Obesity and Metabolism, EarlyView.

Source: Diabetes, Obesity and Metabolism - October 25, 2018 Category: Endocrinology Authors: Myfanwy C. Geyer, Thomas Sullivan, Andrew Tai, Judith M. Morton, Suzanne Edwards, A. James Martin, Shiree J. Perano, Lucia Gagliardi, Christopher K. Rayner, Michael Horowitz, Jennifer J. Couper Source Type: research